TP53 and cancer: Our stratified analysis by cancer type (e.g., colon vs. rectum adenocarcinoma) revealed significant differences in TP53 pathway alterations between early‐onset Hispanic/Latino and non‐Hispanic White patients, suggesting that ethnic‐specific variations may be pronounced for colon cancer.